Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU
Recruiting
N/A
Interventional Study
Intensive Care Unit (ICU) Admission
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,200 (estimated)
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this randomized clinical trial is to determine whether a biomarker-signature (BV) supported antibiotic treatment decision matrix can have a beneficial impact on antibiotic use and patient outcomes in an ICU population.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Admitted to the Intensive Care Unit (ICU)
* Started on antibiotics for any suspected or confirmed infection in the preceding 72 hours (about 3 days)
* Treating doctor(s) willing to consider BV test result in antibiotic treatment decision making
Exclusion Criteria:
* Severe i…
Contacts